AGENDA AT GLANCE
Day 0 | 4 November 2025 |
PRE-CONFERENCE WORKSHOP BY TOFFLON |
Day 1 5 November 2025 | Day 2 6 November 2025 |
|---|---|
Advancing Vaccine Development in SEA | Next-Generation Vaccine Platforms and Delivery Mechanisms |
Exhibition Viewing & 1-1 Attendees Networking |
Vaccine Discovery and Development | Preventive Vaccines: Advancements in Disease Prevention and Immunization Strategies |
Exhibition Viewing & 1-1 Attendees Networking |
Clinical Trials and Real-World Data in Southeast Asia | Vaccine Safety, Monitoring and Post-Market Surveillance |
Exhibition Viewing & 1-1 Attendees Networking |
Bioprocessing & Manufacturing: Advancing Vaccine Formulation, Tech Transfer, and Scale-Up | Vaccine Coverage and Equity |
End of Conference Day 1 | End of Conference Day 2 |
AGENDA AT GLANCE
Day 1 5 November 2025 | Day 2 6 November 2025 |
|---|---|
Navigating the Evolving RNA Therapeutic Landscape in Asia
Regulatory Challenges, Strategic Partnerships, and Emerging Opportunities | Novel RNA Modalities and Indications Advancements, Challenges, and Recent Breakthroughs |
Exhibition Viewing & 1-1 Attendees Networking |
Optimizing RNA Synthesis for Scalable Therapeutic Production | RNA Delivery Innovative Mechanisms and Therapeutic Applications |
Exhibition Viewing & 1-1 Attendees Networking |
RNA Mechanisms and Modulation From Cellular Regulation to Synthetic Applications | Next-Gen RNA Platforms Enabling Innovation in Therapeutics and Manufacturing |
Exhibition Viewing & 1-1 Attendees Networking |
Case Study Insights from Asia in Scaling RNA-Based Therapies | Future Directions in RNA Therapeutics Trends and Innovations |
End of Conference Day 1 | End of Conference Day 2 |
